Revolution Medicines RVMD Officer · filings 2026 to 2026 · sold $10.2M · $11.1M noticed on Form 144
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Option or RSU exercised or converted | +2,310 | $33.62 | $78K | 42,075 direct | Filing · EDGAR |
| Oct 26, 2026 | Sale under a 10b5-1 plan | −2,310 | $186.99 | $432K | 39,765 direct | Filing · EDGAR |
| Oct 26, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −2,310 | 91,315 direct | Filing · EDGAR | ||
| Sep 25, 2026 | Option or RSU exercised or converted | +3,121 | $33.62 | $105K | 42,886 direct | Filing · EDGAR |
| Sep 25, 2026 | Sale under a 10b5-1 plan | −3,121 | $200.54 | $626K | 39,765 direct | Filing · EDGAR |
| Sep 25, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −3,121 | 93,625 direct | Filing · EDGAR | ||
| Sep 24, 2026 | Sale under a 10b5-1 plan | −587 | $200.00 | $117K | 39,765 direct | Filing · EDGAR |
| Sep 18, 2026 | Sale under a 10b5-1 plan | −1,764 | $196.94 | $347K | 40,352 direct | Filing · EDGAR |
| Sep 16, 2026 | Sale under a 10b5-1 plan | −27 | $195.05 | $5K | 43,863 direct | Filing · EDGAR |
| Sep 16, 2026 | Sale under a 10b5-1 plan | −1,747 | $199.30 | $348K | 42,116 direct | Filing · EDGAR |
| Sep 10, 2026 | Option or RSU exercised or converted | +9,363 | $33.62 | $315K | 59,338 direct | Filing · EDGAR |
| Sep 10, 2026 | Sale under a 10b5-1 plan | −6,019 | $203.28 | $1.2M | 53,319 direct | Filing · EDGAR |
| Sep 10, 2026 | Sale under a 10b5-1 plan | −5,530 | $204.14 | $1.1M | 47,789 direct | Filing · EDGAR |
| Sep 10, 2026 | Sale under a 10b5-1 plan | −2,420 | $205.05 | $496K | 45,369 direct | Filing · EDGAR |
| Sep 10, 2026 | Sale under a 10b5-1 plan | −1,179 | $206.10 | $243K | 44,190 direct | Filing · EDGAR |
| Sep 10, 2026 | Sale under a 10b5-1 plan | −300 | $207.17 | $62K | 43,890 direct | Filing · EDGAR |
| Sep 10, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −9,363 | 96,746 direct | Filing · EDGAR | ||
| Jun 16, 2026 | Open-market or private sale | −4,615 | $156.12 | $720K | 49,975 direct | Filing · EDGAR |
| May 26, 2026 | Option or RSU exercised or converted | +3,121 | $33.62 | $105K | 57,521 direct | Filing · EDGAR |
| May 26, 2026 | Sale under a 10b5-1 plan | −700 | $153.30 | $107K | 56,821 direct | Filing · EDGAR |
| May 26, 2026 | Sale under a 10b5-1 plan | −2,000 | $154.06 | $308K | 54,821 direct | Filing · EDGAR |
| May 26, 2026 | Sale under a 10b5-1 plan | −421 | $154.82 | $65K | 54,400 direct | Filing · EDGAR |
| May 26, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −3,121 | 106,109 direct | Filing · EDGAR | ||
| Apr 27, 2026 | Option or RSU exercised or converted | +3,120 | $33.62 | $105K | 57,520 direct | Filing · EDGAR |
| Apr 27, 2026 | Sale under a 10b5-1 plan | −1,671 | $131.66 | $220K | 55,849 direct | Filing · EDGAR |
| Apr 27, 2026 | Sale under a 10b5-1 plan | −1,049 | $132.88 | $139K | 54,800 direct | Filing · EDGAR |
| Apr 27, 2026 | Sale under a 10b5-1 plan | −400 | $134.34 | $54K | 54,400 direct | Filing · EDGAR |
| Apr 27, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −3,120 | 109,230 direct | Filing · EDGAR | ||
| Mar 25, 2026 | Option or RSU exercised or converted | +37,450 | $33.62 | $1.3M | 91,850 direct | Filing · EDGAR |
| Mar 25, 2026 | Sale under a 10b5-1 plan | −1,800 | $93.22 | $168K | 90,050 direct | Filing · EDGAR |
| Mar 25, 2026 | Sale under a 10b5-1 plan | −3,128 | $94.16 | $295K | 86,922 direct | Filing · EDGAR |
| Mar 25, 2026 | Sale under a 10b5-1 plan | −21,086 | $95.49 | $2M | 65,836 direct | Filing · EDGAR |
| Mar 25, 2026 | Sale under a 10b5-1 plan | −11,036 | $96.43 | $1.1M | 54,800 direct | Filing · EDGAR |
| Mar 25, 2026 | Sale under a 10b5-1 plan | −400 | $97.21 | $39K | 54,400 direct | Filing · EDGAR |
| Mar 25, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −37,450 | 112,350 direct | Filing · EDGAR |
